Proposals to Refuse to Approve Supplemental New Drug Applications: Bromday (Bromfenac Ophthalmic Solution), 0.09; Opportunity for Hearing
Title: Exhibit C - Submission of ISTA Pharmaceuticals, Inc. in Response to Notice of Oppurtinity for a Hearing
Title: Exhibit A - FDA to ISTA Pharmaceuticals, Inc. Letter
Title: Exhibit B - List of Post-Surgery Ophthalmic Products and Labeling
Exhibits to Submission of ISTA Pharmaceuticals, Inc.
This is comment on Notice
Proposals to Refuse to Approve Supplemental New Drug Applications: Bromday (Bromfenac Ophthalmic Solution), 0.09; Opportunity for Hearing
View Comment
Attachments:
Exhibit C - Submission of ISTA Pharmaceuticals, Inc. in Response to Notice of Oppurtinity for a Hearing
Title:
Exhibit C - Submission of ISTA Pharmaceuticals, Inc. in Response to Notice of Oppurtinity for a Hearing
Exhibit A - FDA to ISTA Pharmaceuticals, Inc. Letter
Title:
Exhibit A - FDA to ISTA Pharmaceuticals, Inc. Letter
Exhibit B - List of Post-Surgery Ophthalmic Products and Labeling
Title:
Exhibit B - List of Post-Surgery Ophthalmic Products and Labeling
Related Comments
Public Submission Posted: 09/07/2011 ID: FDA-2011-N-0513-0003
Oct 03,2011 11:59 PM ET
Public Submission Posted: 10/17/2011 ID: FDA-2011-N-0513-0005
Oct 03,2011 11:59 PM ET
Public Submission Posted: 10/17/2011 ID: FDA-2011-N-0513-0006
Oct 03,2011 11:59 PM ET